Horizon / Plein textes La base de ressources documentaires de l'IRD

IRD

Publications des scientifiques de l'IRD

Kieffer A., Paboriboune P., Crepey P., Flaissier B., Souvong V., Steenkeste N., Salez N., Babin F. X., Longuet C., Carrat F., Flahault A., de Lamballerie Xavier. (2013). 2009 A(H1N1) seroconversion rates and risk factors among the general population in Vientiane capital, Laos. Plos One, 8 (4), e61909. ISSN 1932-6203

Lien direct chez l'éditeur doi:10.1371/journal.pone.0061909

Titre
2009 A(H1N1) seroconversion rates and risk factors among the general population in Vientiane capital, Laos
Année de publication2013
Type de documentArticle référencé dans le Web of Science WOS:000317908700064
AuteursKieffer A., Paboriboune P., Crepey P., Flaissier B., Souvong V., Steenkeste N., Salez N., Babin F. X., Longuet C., Carrat F., Flahault A., de Lamballerie Xavier.
SourcePlos One, 2013, 8 (4), p. e61909. p. e61909 ISSN 1932-6203
RésuméObjective: To assess 2009 A(H1N1) seroconversion rates and their determinants within an unvaccinated population in Vientiane Capital, Laos. Methods: CoPanFlu Laos, a general population cohort of 807 households and 4,072 participants was established in March 2010. Sociodemographic data, epidemiological data, and capillary blood samples were collected from all the household members in March, and again in October 2010, in order to assess the level of antibodies to 2009 A(H1N1) with the haemagglutination inhibition assay. 2009 A(H1N1) seroconversion was defined as a fourfold or greater increase in titre between inclusion and follow-up. Determinants for pandemic influenza infection were studied using the generalized estimating equations model, taking household clustering into account. Results: Between March and November 2010, 3,524 paired sera were tested. Prior to the pandemic, our cohort was almost completely vaccine-naive for seasonal influenza. The overall seroconversion rate among nonvaccinated individuals (n = 2,810) was 14.3% (95% CI [13.0, 15.6]), with the highest rate for participants under 20 yo (19.8%, 95% CI [17.4, 22.4]) and the lowest rate for participants over 60 yo (6.5%, 95% CI [3.7, 10.4]). Participants with lower baseline titres had significantly higher infection rates, with a dose-effect relationship. Odds ratios (ORs) ranged from 76.5 (95% CI [27.1, 215.8]), for those with a titre at inclusion of 1: 10, to 8.1 (95% CI [3.3, 20.4]), for those with a titre of 1: 40. Having another household member with a titre >= 1: 80 was associated with a higher likelihood of immunity (OR = 3.3, 95% CI [2.8, 3.9]). Conclusion: The determinants and age distribution for seroconversion within a vaccine-naive population were similar to those found in developed countries. This pandemic was characterized by strong epidemiological determinants, regardless of geographical zone and level of development. Moreover, we detected pre-existing cross-reacting antibodies in participants over 60 yo, which could not have originated from former multiple vaccination as has been suggested elsewhere.
Plan de classementEntomologie médicale / Parasitologie / Virologie [052] ; Santé : généralités [050]
Descr. géo.LAOS
LocalisationFonds IRD
Identifiant IRDPAR00010523
Lien permanenthttp://www.documentation.ird.fr/hor/PAR00010523

Export des données

Disponibilité des documents

Télechargment fichier PDF téléchargeable

Lien sur le Web lien chez l'éditeur

Accès réservé en accès réservé

HAL en libre accès sur HAL


Accès aux documents originaux :

Le FDI est labellisé CollEx

Accès direct

Bureau du chercheur

Site de la documentation

Espace intranet IST (accès réservé)

Suivi des publications IRD (accès réservé)

Mentions légales

Services Horizon

Poser une question

Consulter l'aide en ligne

Déposer une publication (accès réservé)

S'abonner au flux RSS

Voir les tableaux chronologiques et thématiques

Centres de documentation

Bondy

Montpellier (centre IRD)

Montpellier (MSE)

Cayenne

Nouméa

Papeete

Abidjan

Dakar

Niamey

Ouagadougou

Tunis

La Paz

Quito